Anesthetic Effect – Pipeline Review, H1 2017

Global Markets Direct’s, ‘Anesthetic Effect – Pipeline Review, H1 2017’, provides an overview of the Anesthetic Effect pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Anesthetic Effect, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Anesthetic Effect and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

– The report provides a snapshot of the global therapeutic landscape of Anesthetic Effect

– The report reviews pipeline therapeutics for Anesthetic Effect by companies and universities/research institutes based on information derived from company and industry-specific sources

– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

– The report reviews key players involved Anesthetic Effect therapeutics and enlists all their major and minor projects

– The report assesses Anesthetic Effect therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

– The report summarizes all the dormant and discontinued pipeline projects

– The report reviews latest news related to pipeline therapeutics for Anesthetic Effect

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of therapeutics under development for Anesthetic Effect

- Identify potential new clients or partners in the target demographic

- Develop strategic initiatives by understanding the focus areas of leading companies

- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding Anesthetic Effect pipeline depth and focus of Indication therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Companies mentioned

4P Therapeutics LLC

Biolab Farmaceutica Ltda

Drawbridge Pharmaceuticals Pty Ltd

Expanesthetics Inc

Jiangsu Hengrui Medicine Co Ltd

Lee's Pharmaceutical Holdings Ltd

Lipicard Technologies Ltd

NanoMedex Pharmaceuticals Inc

Paion AG

Phosphagenics Ltd

Physica Pharma

Primex Pharmaceuticals Oy

Proteus SA

Sphaera Pharma Pvt Ltd

Taiwan Liposome Company Ltd

The Medicines Company

WEX Pharmaceuticals Inc

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Introduction 5

Global Markets Direct Report Coverage 5

Anesthetic Effect - Overview 6

Anesthetic Effect - Therapeutics Development 7

Pipeline Overview 7

Pipeline by Companies 8

Pipeline by Universities/Institutes 10

Products under Development by Companies 11

Products under Development by Universities/Institutes 13

Anesthetic Effect - Therapeutics Assessment 14

Assessment by Target 14

Assessment by Mechanism of Action 16

Assessment by Route of Administration 18

Assessment by Molecule Type 20

Anesthetic Effect - Companies Involved in Therapeutics Development 21

4P Therapeutics LLC 21

Biolab Farmaceutica Ltda 21

Drawbridge Pharmaceuticals Pty Ltd 22

Expanesthetics Inc 22

Jiangsu Hengrui Medicine Co Ltd 23

Lee's Pharmaceutical Holdings Ltd 23

Lipicard Technologies Ltd 24

NanoMedex Pharmaceuticals Inc 24

Paion AG 25

Phosphagenics Ltd 25

Physica Pharma 26

Primex Pharmaceuticals Oy 26

Proteus SA 27

Sphaera Pharma Pvt Ltd 27

Taiwan Liposome Company Ltd 28

The Medicines Company 29

WEX Pharmaceuticals Inc 29

Anesthetic Effect - Drug Profiles 30

alphaxalone - Drug Profile 30

bupivacaine hydrochloride SR - Drug Profile 32

Carboetomidate - Drug Profile 33

gabafol - Drug Profile 34

HSK-3486 - Drug Profile 35

lidocaine hydrochloride - Drug Profile 36

lidocaine hydrochloride - Drug Profile 37

LT-1121 - Drug Profile 38

LT-1123 - Drug Profile 39

MDCO-700 - Drug Profile 40

Methoxycarbonyl Carboetomidate - Drug Profile 42

Methoxycarbonyl Etomidate - Drug Profile 43

midazolam hydrochloride - Drug Profile 45

neosaxitoxin - Drug Profile 46

PB-5109 - Drug Profile 48

PHY-301 - Drug Profile 49

propofol - Drug Profile 50

propofol - Drug Profile 51

propofol - Drug Profile 52

remimazolam - Drug Profile 53

remimazolam - Drug Profile 60

Small Molecule for General Anesthetic Effect - Drug Profile 61

Small Molecules for General Anesthetic Effect - Drug Profile 62

Small Molecules to Inhibit NMDA Receptor for Anesthesia - Drug Profile 63

SPR-819 - Drug Profile 64

Tetrodotoxin - Drug Profile 65

TLC-590 - Drug Profile 67

Anesthetic Effect - Dormant Projects 68

Anesthetic Effect - Discontinued Products 69

Anesthetic Effect - Product Development Milestones 70

Featured News & Press Releases 70

Appendix 82

Methodology 82

Coverage 82

Secondary Research 82

Primary Research 82

Expert Panel Validation 82

Contact Us 82

Disclaimer 83

List of Tables

List of Tables

Number of Products under Development for Anesthetic Effect, H1 2017

Number of Products under Development by Companies, H1 2017

Number of Products under Development by Universities/Institutes, H1 2017

Products under Development by Companies, H1 2017

Products under Development by Companies, H1 2017 (Contd..1), H1 2017

Products under Development by Universities/Institutes, H1 2017

Number of Products by Stage and Target, H1 2017

Number of Products by Stage and Mechanism of Action, H1 2017

Number of Products by Stage and Route of Administration, H1 2017

Number of Products by Stage and Molecule Type, H1 2017

Anesthetic Effect – Pipeline by 4P Therapeutics LLC, H1 2017

Anesthetic Effect – Pipeline by Biolab Farmaceutica Ltda, H1 2017

Anesthetic Effect – Pipeline by Drawbridge Pharmaceuticals Pty Ltd, H1 2017

Anesthetic Effect – Pipeline by Expanesthetics Inc, H1 2017

Anesthetic Effect – Pipeline by Jiangsu Hengrui Medicine Co Ltd, H1 2017

Anesthetic Effect – Pipeline by Lee's Pharmaceutical Holdings Ltd, H1 2017

Anesthetic Effect – Pipeline by Lipicard Technologies Ltd, H1 2017

Anesthetic Effect – Pipeline by NanoMedex Pharmaceuticals Inc, H1 2017

Anesthetic Effect – Pipeline by Paion AG, H1 2017

Anesthetic Effect – Pipeline by Phosphagenics Ltd, H1 2017

Anesthetic Effect – Pipeline by Physica Pharma, H1 2017

Anesthetic Effect – Pipeline by Primex Pharmaceuticals Oy, H1 2017

Anesthetic Effect – Pipeline by Proteus SA, H1 2017

Anesthetic Effect – Pipeline by Sphaera Pharma Pvt Ltd, H1 2017

Anesthetic Effect – Pipeline by Taiwan Liposome Company Ltd, H1 2017

Anesthetic Effect – Pipeline by The Medicines Company, H1 2017

Anesthetic Effect – Pipeline by WEX Pharmaceuticals Inc, H1 2017

Anesthetic Effect – Dormant Projects, H1 2017

Anesthetic Effect – Discontinued Products, H1 2017

List of Figures

List of Figures

Number of Products under Development for Anesthetic Effect, H1 2017

Number of Products under Development by Companies, H1 2017

Number of Products by Top 10 Targets, H1 2017

Number of Products by Stage and Top 10 Targets, H1 2017

Number of Products by Top 10 Mechanism of Actions, H1 2017

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017

Number of Products by Routes of Administration, H1 2017

Number of Products by Stage and Routes of Administration, H1 2017

Number of Products by Stage and Molecule Types, H1 2017

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports